What conditions does Summit Therapeutics run trials for?

In our tracked recruiting trials, Summit Therapeutics sponsors trials for Lung cancer, Non-Small Cell Lung Cancer, Colorectal cancer.

Clinical trials sponsored by Summit Therapeutics

Recruiting trials

Conditions studied

Phase 3 3

Condition	Trials
Lung cancer	2
Non-Small Cell Lung Cancer	2
Colorectal cancer	1
Metastatic Colorectal Cancer (CRC)	1

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
NCT05899608 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 260 locations
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
NCT06767514 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 274 locations
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
NCT07228832 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 166 locations

Summit Therapeutics is the lead sponsor of 3 recruiting trials.

No. For the full record, search ClinicalTrials.gov.